June 29, 2018 / 12:29 PM / in 2 months

BUZZ-Aptose Biosciences: Shares jump after U.S. FDA lifts clinical hold on drug

** Canadian drug developer’s shares surge ~15 pct in premarket after the U.S. Food and Drug Administration lifts clinical hold on its experimental blood cancer drug, APTO-253

** Stock on track to post its biggest pct gain in 5 months; stock jumped 45 pct earlier

** APTO says up to 15 clinical centers are expected to participate in the drug’s early-stage trial; screening and dosing will resume as soon as practicable

** Drug’s early-stage trial had been placed on clinical hold in November 2015 after a review found a malfunctioning infusion pump at a clinical site

** APTO’s shares are up ~69 pct YTD (Reporting by John Benny in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below